Independent Assessment and Assurance of 62-Day Cancer Treatment Standard

This opportunity involves conducting an independent assessment and assurance review of The Christie's adherence to the 62-day cancer treatment standard as outlined in their Five-Year Integrated Delivery Plan. The selected supplier will evaluate compliance with this critical performance metric, which measures the time from urgent referral to first definitive cancer treatment. The assessment should provide objective verification of processes, data accuracy, and organizational capacity to meet and maintain this standard. This work supports The Christie's commitment to delivering timely cancer care and improving patient outcomes across their healthcare delivery services.